Biblio
Export 2045 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is M [Clear All Filters]
“Health-Related Quality of Life in Patients with Alzheimer's Disease in Different German Health Care Settings.”, J Alzheimers Dis, vol. 51, no. 2, pp. 545-61, 2016.
, “Heart Rate Spectra Confirm the Presence of Autonomic Dysfunction in Dementia Patients.”, J Alzheimers Dis, vol. 54, no. 2, pp. 657-67, 2016.
, “Heart Rate Spectra Confirm the Presence of Autonomic Dysfunction in Dementia Patients.”, J Alzheimers Dis, vol. 54, no. 2, pp. 657-67, 2016.
, “Hemisphere Asymmetry of Response to Pharmacologic Treatment in an Alzheimer's Disease Mouse Model.”, J Alzheimers Dis, vol. 51, no. 2, pp. 333-8, 2016.
, “High-Throughput Screening for Identification of Blood-Brain Barrier Integrity Enhancers: A Drug Repurposing Opportunity to Rectify Vascular Amyloid Toxicity.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1499-516, 2016.
, “Hippocampal Lipid Homeostasis in APP/PS1 Mice is Modulated by a Complex Interplay Between Dietary DHA and Estrogens: Relevance for Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 459-81, 2016.
, “A History of In Vivo Neutron Activation Analysis in Measurement of Aluminum in Human Subjects.”, J Alzheimers Dis, vol. 50, no. 4, pp. 913-26, 2016.
, “Homocysteine, Infections, Polyamines, Oxidative Metabolism, and the Pathogenesis of Dementia and Atherosclerosis.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1283-1290, 2016.
, “The Identification of Aluminum in Human Brain Tissue Using Lumogallion and Fluorescence Microscopy.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1333-1338, 2016.
, “Immunization Against Specific Fragments of Neurotrophin p75 Receptor Protects Forebrain Cholinergic Neurons in the Olfactory Bulbectomized Mice.”, J Alzheimers Dis, vol. 53, no. 1, pp. 289-301, 2016.
, “Immunization with Small Amyloid-β-derived Cyclopeptide Conjugates Diminishes Amyloid-β-Induced Neurodegeneration in Mice.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1111-23, 2016.
, “Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.”, J Alzheimers Dis, vol. 51, no. 2, pp. 405-15, 2016.
, “Impact of Depressive Symptoms on Memory for Emotional Words in Mild Cognitive Impairment and Late-Life Depression.”, J Alzheimers Dis, vol. 52, no. 2, pp. 451-62, 2016.
, “Impacts of Illiteracy on the Risk of Dementia: A Global Health Perspective.”, J Alzheimers Dis, vol. 53, no. 2, pp. 731-41, 2016.
, “Impaired Autophagy in APOE4 Astrocytes.”, J Alzheimers Dis, vol. 51, no. 3, pp. 915-27, 2016.
, “Impaired Autophagy in APOE4 Astrocytes.”, J Alzheimers Dis, vol. 51, no. 3, pp. 915-27, 2016.
, “Improved Neuroprotection Provided by Drug Combination in Neurons Exposed to Cell-Derived Soluble Amyloid-β Peptide.”, J Alzheimers Dis, vol. 52, no. 3, pp. 975-87, 2016.
, “Increased Expression of Readthrough Acetylcholinesterase Variants in the Brains of Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 53, no. 3, pp. 831-41, 2016.
, “Increased Intrinsic Activity of Medial-Temporal Lobe Subregions is Associated with Decreased Cortical Thickness of Medial-Parietal Areas in Patients with Alzheimer's Disease Dementia.”, J Alzheimers Dis, vol. 51, no. 1, pp. 313-26, 2016.
, “Increased Levels of Extracellular Microvesicle Markers and Decreased Levels of Endocytic/Exocytic Proteins in the Alzheimer's Disease Brain.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1671-1686, 2016.
, “Increased Levels of Extracellular Microvesicle Markers and Decreased Levels of Endocytic/Exocytic Proteins in the Alzheimer's Disease Brain.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1671-1686, 2016.
, “Increased Total Homocysteine Levels Predict the Risk of Incident Dementia Independent of Cerebral Small-Vessel Diseases and Vascular Risk Factors.”, J Alzheimers Dis, vol. 49, no. 2, pp. 503-13, 2016.
, “Increased Total Homocysteine Levels Predict the Risk of Incident Dementia Independent of Cerebral Small-Vessel Diseases and Vascular Risk Factors.”, J Alzheimers Dis, vol. 49, no. 2, pp. 503-13, 2016.
, “Inflammation, Antiinflammatory Agents, and Alzheimer's Disease: The Last 22 Years.”, J Alzheimers Dis, vol. 54, no. 3, pp. 853-857, 2016.
, “Inflammation, Antiinflammatory Agents, and Alzheimer's Disease: The Last 22 Years.”, J Alzheimers Dis, vol. 54, no. 3, pp. 853-857, 2016.
,